Menu
Log in
Log in

News

  • Home
  • Resources
  • Literature Updates
  • Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

15 Apr 2019 6:04 AM | Michele O'Bright (Administrator)

Prof Salah-Eddin Al-Batran, Prof Nils Homann, Claudia Pauligk, Thorsten O. Goetze, Prof Johannes Meiler, Prof Stefan Kasper, Hans-Georg Kopp, Frank Mayer, Georg Martin Haag, Kim Luley, Udo Lindig, Prof Wolff Schmiegel, Michael Pohl, Prof Jan Stoehlmacher, Prof Gunnar Folprecht, Stephan Probst, Nicole Prasnikar, Prof Wolfgang Fischbach, Rolf Mahlberg, Prof Jörg Trojan, Prof Michael Koenigsmann, Prof Uwe M Martens, Peter Thuss-Patience, Matthias Egger, Andreas Block, Prof Volker Heinemann, Prof Gerald Illerhaus, Prof Markus Moehler, Michael Schenk, Prof Frank Kullmann, Prof Dirk M Behringer, Prof Michael Heike, Daniel Pink, Christian Teschendorf, Carmen Löhr, Prof Helga Bernhard, Gunter Schuch, Volker Rethwisch, Ludwig Fischer von Weikersthal, Prof Jörg T Hartmann, Michael Kneba, Severin Daum, Karsten Schulmann, Jörg Weniger, Sebastian Belle, Prof Timo Gaiser, Prof Fuat S Oduncu, Martina Güntner, Wael Hozaeel, Alexander Reichart, Prof Elke Jäger, Prof Thomas Kraus, Prof Stefan Mönig, Prof Wolf O Bechstein, Prof Martin Schuler, Harald Schmalenberg, Prof Ralf D Hofheinz.

Click here to read full abstract.


Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software